Additional supporting information may be found in the online version of this article:
Video S1 Image-guided surgery in breast cancer (wmw file) Video S2 Camouflaged octopus (mp4 file)
Video S3 Mouse breast cancer (mov file) Video S4 Mouse ovarian cancer (m4v file)
Video S5 Human targeted fluorescence detection of ovarian cancer (mov file)
1. Kriss TC, Kriss VM. History of the oper-ating microscope: from magnifying glas to microneurosurgery. Neurosurgery.
1998 Apr;42(4):899-907.
2. Moore GE. Fluorescein as an Agent in the Differentiation of Normal and Malignant Tissues. Science. 1947 Aug 8;106(2745):130-1.
3. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ. Intraopera-tive detection of malignant gliomas by 5-aminolevulinic acid-induced porphy-rin fluorescence. Neurosurgery. 1998 Mar;42(3):518-25.
4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994 Sep;220(3):391-398.
5. van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntzia-christos V. Intraoperative tumor-specific fluorescence imaging in ovarian can-cer by folate receptor-α targeting: first in-human results. Nat Med. 2011 Sep 18;17(10):1315-9.
6. Crane LM, Themelis G, Arts HJ, Bud-dingh KT, Brouwers AH, Ntziachristos V, van Dam GM, van der Zee AG. Intra-operative near-infrared fluorescence im-aging for sentinel lymph node detection
in vulvar cancer: first clinical results.
Gynecol Oncol. 2011 Feb;120(2):291-5.
7. Holm C, Mayr M, Höfter E, Becker A, Pfeiffer UJ, Mühlbauer W. Intraoper-ative evaluation of skin-flap viability using laser-induced fluorescence of in-docyanine green. Br J Plast Surg. 2002 Dec;55(8):635-44.
8. Spinoglio G, Priora F, Bianchi PP, Lucido FS, Licciardello A, Maglione V, Grosso F, Quarati R, Ravazzoni F, Lenti LM. Re-al-time near-infrared (NIR) fluorescent cholangiography in single-site robotic cholecystectomy (SSRC): a single-insti-tutional prospective study. Surg Endosc.
2013 Jun;27(6):2156-62.
9. van der Vorst JR, Schaafsma BE, Hut-teman M, Verbeek FP, Liefers GJ, Hart-grink HH, Smit VT, Löwik CW, van de Velde CJ, Frangioni JV, Vahrmeijer AL.
Near-infrared fluorescence-guided re-section of colorectal liver metastases.
Cancer. 2013 Sep 15;119(18):3411-8.
10. Frangioni JV. New technologies for hu-man cancer imaging. J Clin Oncol. 2008 Aug 20;26(24):4012-21.
11. Krekel NM, Haloua MH, Lopes Car-dozo AM, de Wit RH, Bosch AM, de Widt-Levert LM, Muller S, van der Veen H, Bergers E, de Lange de Klerk ES, Mei-jer S, van den Tol MP. Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a mul-ticentre, randomised controlled trial.
REFERENCES
Lancet Oncol. 2013 Jan;14(1):48-54.
12. Ntziachristos V. Fluorescence molec-ular imaging. Annu Rev Biomed Eng.
2006;8:1-33.
13. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med. 2003 Jan;9(1):123-8.
14. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003; 9:123–128.
15. Vinegoni C, Razansky D, Figueire-do JL, NahrenFigueire-dorf M, Ntziachristos V, Weissleder R. Normalized Born ratio for fluorescence optical projection tomogra-phy. Opt Lett. 2009 Feb 1;34(3):319-21.
16. Glatz J, Varga J, Garcia-Allende PB, Koch M, Greten FR, Ntziachristos V. Concur-rent video-rate color and near-infrared fluorescence laparoscopy. J Biomed Opt.
2013 Oct;18(10):101302.
17. Garcia-Allende PB, Glatz J, Koch M, Tjalma JJ, Hartmans E, Terwisscha van Scheltinga AG, Symvoulidis P, van Dam GM, Nagengast WB, Ntziachristos V.
Towards clinically translatable NIR flu-orescence molecular guidance for colo-noscopy. Biomed Opt Express. 2013 Dec 4;5(1):78-92.
18. Lee LN, Smith DF, Boahene KD, Byrne PJ. Intraoperative laser-assisted indo-cyanine green imaging for objective measurement of the vascular delay tech-nique in locoregional head and neck flaps. JAMA Facial Plast Surg. 2014 Sep-Oct;16(5):343-7.
19. Keereweer S, Kerrebijn JD, van Driel PB,
Xie B, Kaijzel EL, Snoeks TJ, Que I, Hut-teman M, van der Vorst JR, Mieog JS, Vahrmeijer AL, van de Velde CJ, Baaten-burg de Jong RJ, Löwik CW. Optical im-age-guided surgery--where do we stand?
Mol Imaging Biol. 2011 Apr;13(2):199-207.
20. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Can-cer Cell. 2008 Jun;13(6):472-82.
21. White AG, Fu N, Leevy WM, Lee JJ, Blasco MA, Smith BD. Optical imaging of bacterial infection in living mice us-ing deep-red fluorescent squaraine ro-taxane probes. Bioconjug Chem. 2010 Jul 21;21(7):1297-304.
22. Hintersteiner M, Enz A, Frey P, Jaton AL, Kinzy W, Kneuer R, Neumann U, Rudin M, Staufenbiel M, Stoeckli M, Wiederhold KH, Gremlich HU. In vivo detection of amyloid-beta deposits by near-infrared imaging using an ox-azine-derivative probe. Nat Biotechnol.
2005 May;23(5):577-83.
23. van Oosten M, Schäfer T, Gazendam JA, Ohlsen K, Tsompanidou E, de Goffau MC, Harmsen HJ, Crane LM, Lim E, Francis KP, Cheung L, Olive M, Ntzia-christos V, van Dijl JM, van Dam GM.
Real-time in vivo imaging of invasive- and biomaterial-associated bacterial in-fections using fluorescently labelled van-comycin. Nat Commun. 2013;4:2584.
24. Wallis de Vries BM, Hillebrands JL, van Dam GM, Tio RA, de Jong JS, Slart RH, Zeebregts CJ. Images in cardiovascular
medicine. Multispectral near-infrared fluorescence molecular imaging of ma-trix metalloproteinases in a human ca-rotid plaque using a matrix-degrading metalloproteinase-sensitive activata-blefluorescent probe. Circulation. 2009 May 26;119(20):e534-6.
25. van Oosten M, Crane LM, Bart J, van Leeuwen FW, van Dam GM. Selecting Potential Targetable Biomarkers for Im-aging Purposes in Colorectal Cancer Us-ing TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol. 2011 Apr 1;4(2):71-82.
26. Themelis G, Harlaar NJ, Kelder W, Bart J, Sarantopoulos A, van Dam GM, Ntzia-christos V. Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.
Ann Surg Oncol. 2011 Nov;18(12):3506-13.
27. Harlaar NJ, Kelder W, Sarantopoulos A, Bart J, Themelis G, van Dam GM, Ntzia-christos V. Real-time near infrared flu-orescence (NIRF) intra-operative imag-ing in ovarian cancer usimag-ing an α(v)β(3-) integrin targeted agent. Gynecol Oncol.
2013 Mar;128(3):590-5.
28. Kelder W, Nimura H, Takahashi N, Mit-sumori N, van Dam GM, Yanaga K. Sen-tinel node mapping with indocyanine green (ICG) and infrared ray detec-tion in early gastric cancer: an accurate method that enables a limited lymph-adenectomy. Eur J Surg Oncol. 2010 Jun;36(6):552-8.
29. Liu DZ, Mathes DW, Zenn MR, Neli-gan PC. The application of indocyanine green fluorescence angiography in plas-tic surgery. J Reconstr Microsurg. 2011 Jul;27(6):355-64.
30. Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmei-jer AL. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided onco-logic surgery. J Surg Oncol. 2011 Sep 1;104(3):323-32.
31. Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, Hasegawa K, Beck Y, Fukayama M, Kokudo N. Re-al-time identification of liver cancers by using indocyanine green fluorescent im-aging. Cancer. 2009 Jun 1;115(11):2491-504.
32. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74.
33. Day KE, Sweeny L, Kulbersh B, Zinn KR, Rosenthal EL. Preclinical comparison of near-infrared-labeled cetuximab and pa-nitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol. 2013 Dec;15(6):722-9.
34. Stummer W, Reulen HJ, Novotny A, Stepp H, Tonn JC. Fluorescence-guid-ed resections of malignant gliomas--an overview. Acta Neurochir Suppl.
2003;88:9-12.
35. Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of
panitumum-ab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol. 2012 Nov;19(12):3879-87.
36. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachris-tos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG. Intraoperative near-infrared fluorescence tumor imaging with vas-cular endothelial growth factor and hu-man epidermal growth factor receptor 2 targeting antibodies. J Nucl Med. 2011 Nov;52(11):1778-85.
37. Rothbauer U, Zolghadr K, Tillib S, Nowak D, Schermelleh L, Gahl A, Back-mann N, Conrath K, Muyldermans S, Cardoso MC, Leonhardt H. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat Methods.
2006 Nov;3(11):887-9.
38. Gong H, Kovar JL, Cheung L, Rosen-thal EL, Olive DM. A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imag-ing of EGFR- and EGFRvIII-express-ing tumors. Cancer Biol Ther. 2014 Feb;15(2):185-93.
39. Korb ML, Hartman YE, Kovar J, Zinn KR, Bland KI, Rosenthal EL. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer. J Surg Res. 2014 May 1;188(1):119-28.
40. Nagengast WB, de Vries EG, Hospers GA, Mulder NH, de Jong JR, Hollema
H, Brouwers AH, van Dongen GA, Perk LR, Lub-de Hooge MN. In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. J Nucl Med. 2007 Aug;48(8):1313-9.
41. Nagengast WB, de Vries EG, Hospers GA, Mulder NH, de Jong JR, Hollema H, Brouwers AH, van Dongen GA, Perk LR, Lub-de Hooge MN. In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. J Nucl Med. 2007 Aug;48(8):1313-9.
42. Terwisscha van Scheltinga AG, Berghu-is P, NienhuBerghu-is HH, Timmer-Bosscha H, Pot L, Gaykema SB, Lub-de Hooge MN, Kosterink JG, de Vries EG, Schröder CP.
Visualising dual downregulation of in-sulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer. Eur J Can-cer. 2014 Sep;50(14):2508-16.
43. Mahmood U, Weissleder R. Near-in-frared optical imaging of proteas-es in cancer. Mol Cancer Ther. 2003 May;2(5):489-96.
44. Wunderbaldinger P, Turetschek K, Bremer C. Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromo-lecular optical probe. Eur Radiol. 2003 Sep;13(9):2206-11.
45. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor im-aging by means of proteolytic acti-vation of cell-penetrating peptides.
Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17867-72.
46. Nguyen QT, Olson ES, Aguilera TA, Ji-ang T, Scadeng M, Ellies LG, Tsien RY.
Surgery with molecular fluorescence im-aging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4317-22.
47. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008 Apr 3;452(7187):580-9.
48. Keereweer S, Van Driel PB, Snoeks TJ, Kerrebijn JD, Baatenburg de Jong RJ, Vahrmeijer AL, Sterenborg HJ, Löwik CW. Optical image-guided cancer sur-gery: challenges and limitations. Clin Cancer Res. 2013 Jul 15;19(14):3745-54.
49. Bu L, Shen B, Cheng Z. Fluorescent im-aging of cancerous tissues for targeted surgery. Adv Drug Deliv Rev. 2014 Sep 30;76:21-38.
50. van Dongen GA, Visser GW, Vrouen-raets MB. Photosensitizer-antibody conjugates for detection and therapy of cancer. Adv Drug Deliv Rev. 2004 Jan 13;56(1):31-52.
51. Vrouenraets MB, Visser GW, Snow GB, van Dongen GA. Basic principles, ap-plications in oncology and improved se-lectivity of photodynamic therapy. Anti-cancer Res. 2003 Jan-Feb;23(1B):505-22.
52. Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T. Photophysics and pho-tochemistry of photodynamic therapy:
fundamental aspects. Lasers Med Sci.
2009 Mar;24(2):259-68.
53. Ntziachristos V. Going deeper than microscopy: the optical imaging fron-tier in biology. Nat Methods. 2010 Aug;7(8):603-14.
54. Wang LV, Hu S. Photoacoustic to-mography: in vivo imaging from or-ganelles to organs. Science. 2012 Mar 23;335(6075):1458-62.
55. Ntziachristos V, Razansky D. Molecular imaging by means of multispectral op-toacoustic tomography (MSOT). Chem Rev. 2010 May 12;110(5):2783-94.
56. Luke GP, Yeager D, Emelianov SY. Bio-medical applications of photoacoustic imaging with exogenous contrast agents.
Ann Biomed Eng. 2012 Feb;40(2):422-37.
57. Buehler A, Kacprowicz M, Taruttis A, Ntziachristos V. Real-time handheld multispectral optoacoustic imaging. Opt Lett. 2013 May 1;38(9):1404-6.
58. Kim C, Erpelding TN, Jankovic L, Wang LV. Performance benchmarks of an ar-ray-based hand-held photoacoustic probe adapted from a clinical ultrasound system for non-invasive sentinel lymph node imaging. Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4644-50.
59. Yang JM, Favazza C, Chen R, Yao J, Cai X, Maslov K, Zhou Q, Shung KK, Wang LV. Simultaneous functional photo-acoustic and ultrasonic endoscopy of internal organs in vivo. Nat Med. 2012 Aug;18(8):1297-1302.
60. Herzog E, Taruttis A, Beziere N, Lutich AA, Razansky D, Ntziachristos V. Opti-cal imaging of cancer heterogeneity with multispectral optoacoustic tomography.
Radiology. 2012 May;263(2):461-8.
61. Li ML, Oh JT, Xie X, Ku G, Wang W, Li C et al. Simultaneous molecular and hy-poxia imaging of brain tumors in vivo using spectroscopic photo acoustic to-mography. Proc IEEE 2008; 96:481–489.
62. Dima A, Gateau J, Claussen J, Wilhelm D, Ntziachristos V. Optoacoustic imag-ing of blood perfusion: techniques for intraoperative tissue viability assess-ment. J Biophotonics. 2013 Jun;6(6-7):485-92.
63. Taruttis A, Rosenthal A, Kacprowicz M, Burton NC, Ntziachristos V. Multiscale multispectral optoacoustic tomography by a stationary wavelet transform prior to unmixing. IEEE Trans Med Imaging.
2014 May;33(5):1194-202.
64. Jose J, Grootendorst DJ, Vijn TW, Wouters MW, van Boven H, van Leeu-wen TG, Steenbergen W, Ruers TJ, Manohar S. Initial results of imaging melanoma metastasis in resected human lymph nodes using photoacoustic com-puted tomography. J Biomed Opt. 2011 Sep;16(9):096021.
65. Langhout GC, Grootendorst DJ, Nieweg OE, Wouters MW, van der Hage JA, Jose J, van Boven H, Steenbergen W, Mano-har S, Ruers TJ. Detection of melanoma metastases in resected human lymph nodes by noninvasive multispectral
pho-toacoustic imaging. Int J Biomed Imag-ing. 2014;2014:163652.
66. Zhou Y, Xing W, Maslov KI, Cornelius LA, Wang LV. Handheld photoacoustic microscopy to detect melanoma depth in vivo. Opt Lett. 2014 Aug 15;39(16):4731-4.
67. Wang B, Karpiouk A, Yeager D, Amirian J, Litovsky S, Smalling R, Emelianov S.
In vivo intravascular ultrasound-guid-ed photoacoustic imaging of lipid in plaques using an animal model of ath-erosclerosis. Ultrasound Med Biol. 2012 Dec;38(12):2098-103.
68. Jansen K, van der Steen AF, Wu M, van Beusekom HM, Springeling G, Li X, Zhou Q, Shung KK, de Kleijn DP, van Soest G. Spectroscopic intravas-cular photoacoustic imaging of lipids in atherosclerosis. J Biomed Opt. 2014 Feb;19(2):026006.
69. Heijblom M, Piras D, Xia W, van Hespen JC, Klaase JM, van den Engh FM, van Leeuwen TG, Steenbergen W, Manohar S. Visualizing breast cancer using the Twente photoacoustic mammoscope:
what do we learn from twelve new pa-tient measurements? Opt Express. 2012 May 21;20(11):11582-97.
70. Ermilov SA, Khamapirad T, Conjusteau A, Leonard MH, Lacewell R, Mehta K, Miller T, Oraevsky AA. Laser opto-acoustic imaging system for detection of breast cancer. J Biomed Opt. 2009 Mar-Apr;14(2):024007.
71. Manohar S, Vaartjes SE, van Hespen JC,
Klaase JM, van den Engh FM, Steenber-gen W, van Leeuwen TG. Initial results of in vivo non-invasive cancer imaging in the human breast using near-infrared photoacoustics. Opt Express. 2007 Sep 17;15(19):12277-85.
72. Taruttis A, Wildgruber M, Kosanke K, Beziere N, Licha K, Haag R, Aichler M, Walch A, Rummeny E, Ntziachristos V.
Multispectral optoacoustic tomography of myocardial infarction. Photoacous-tics. 2012 Dec 10;1(1):3-8.
73. Bao C, Beziere N, del Pino P, Pelaz B, Estrada G, Tian F, Ntziachristos V, de la Fuente JM, Cui D. Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers. Small. 2013 Jan 14;9(1):68-74.
74. Homan KA, Souza M, Truby R, Luke GP, Green C, Vreeland E, Emelianov S. Sil-ver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano. 2012 Jan 24;6(1):641-50.
75. Homan KA, Souza M, Truby R, Luke GP, Green C, Vreeland E, Emelianov S. Sil-ver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano. 2012 Jan 24;6(1):641-50.
76. Chen YS, Frey W, Kim S, Kruizinga P, Homan K, Emelianov S. Silica-coated gold nanorods as photoacoustic signal nanoamplifiers. Nano Lett. 2011 Feb 9;11(2):348-54.
77. Cheng K, Kothapalli SR, Liu H, Koh AL, Jokerst JV, Jiang H, Yang M, Li J, Levi J, Wu JC, Gambhir SS, Cheng Z. Con-struction and validation of nano gold tripods for molecular imaging of living subjects. J Am Chem Soc. 2014 Mar 5;136(9):3560-71.
78. de la Zerda A, Liu Z, Bodapati S, Teed R, Vaithilingam S, Khuri-Yakub BT, Chen X, Dai H, Gambhir SS. Ultrahigh sensi-tivity carbon nanotube agents for pho-toacoustic molecular imaging in living mice. Nano Lett. 2010 Jun 9;10(6):2168-72.
79. Yang X, Skrabalak SE, Li ZY, Xia Y, Wang LV. Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent.
Nano Lett. 2007 Dec;7(12):3798-802.